1. Home
  2. CRDF vs GOAI Comparison

CRDF vs GOAI Comparison

Compare CRDF & GOAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardiff Oncology Inc.

CRDF

Cardiff Oncology Inc.

HOLD

Current Price

$1.64

Market Cap

130.7M

Sector

Health Care

ML Signal

HOLD

GOAI

Eva Live Inc. Common Stock

N/A

Current Price

$3.76

Market Cap

150.5M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CRDF
GOAI
Founded
1999
2015
Country
United States
United States
Employees
N/A
3
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
130.7M
150.5M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
CRDF
GOAI
Price
$1.64
$3.76
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$9.63
N/A
AVG Volume (30 Days)
705.3K
59.1K
Earning Date
05-07-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
27.37
N/A
EPS
N/A
N/A
Revenue
$365,993.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$18.31
Revenue Growth
49.61
N/A
52 Week Low
$1.48
$2.75
52 Week High
$4.56
$6.67

Technical Indicators

Market Signals
Indicator
CRDF
GOAI
Relative Strength Index (RSI) 47.75 45.54
Support Level $1.51 $3.48
Resistance Level $1.68 $4.36
Average True Range (ATR) 0.09 0.35
MACD -0.00 -0.02
Stochastic Oscillator 25.01 23.75

Price Performance

Historical Comparison
CRDF
GOAI

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company that leverages PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies for various cancers with unmet medical needs. The company focuses on targeting tumor vulnerabilities with treatment combinations of onvansertib, its oral and selective PLK1 inhibitor, and standard-of-care (SoC) therapeutics. The firm's clinical program pipeline focuses on indications such as RAS-mutated metastatic colorectal cancer (mCRC), investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma (mPDAC), small cell lung cancer (SCLC), metastatic triple negative breast cancer (mTNBC), and Chronic Myelomonocytic Leukemia (CMML). Geographically, it operates only in the United States.

About GOAI Eva Live Inc. Common Stock

Eva Live Inc is a United States-based technology company that has developed an automated and intelligent advertiser campaign management platform, Eva Platform, which enables advertisers ('customers, clients') to buy advertising space on several digital channels to reach their desired audience. The company also works with Businesses that utilize its in-house digital marketing capabilities, including advice, creative services, account management, production of advertising materials, media planning, and buying.

Share on Social Networks: